Skip to content

Juno Therapeutics, Inc.

CIK 0001594864

← back to feed
Revenue (TTM)
$106.24M
−41.0% YoY FY Feb 2018
Net Income (TTM)
−$357.97M
−15.2% YoY FY Feb 2018
EPS Diluted (TTM)
—
FY Feb 2018
Gross Margin
—
FY Feb 2018
Operating Margin
-346.4%
FY Feb 2018
Net Margin
-337.0%
FY Feb 2018
Free Cash Flow (TTM)
−$252.78M
FY Feb 2018
Cash
$232.78M
FY Feb 2018
Total Debt
$9.95M
FY Feb 2018
Shares Outstanding
116.11M sh
FY Feb 2018

Revenue & Net Income

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings